Form C - Offering Statement:
SEC Accession No. 0001665160-25-000154
Filing Date
2025-01-29
Accepted
2025-01-29 11:07:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9380
2 offeringmemoformc.pdf EX-99 20580168
  Complete submission text file 0001665160-25-000154.txt   28352531
Mailing Address 1401 LAVACA STREET, #851 AUSTIN TX 78701
Business Address 1401 LAVACA STREET, #851 AUSTIN TX 78701 256-445-8007
AlphaRose Therapeutics Inc (Filer) CIK: 0002051498 (see all company filings)

EIN.: 934193310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-35469 | Film No.: 25567524